Please assess the completion status of the following clinical trial:

Trial Title: Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria for donor lung:~1. Recipient to undergo a single or bilateral Lung Transplantation~2. Last donor PaO2/FiO2 ≤ 300mmHg~3. Poor oxygenation and/or poor lung compliance is the primary reason for unsuitability~4. Absence of pneumonia, persistent purulent secretion on bronchoscopy or significant mechanical trauma~Exclusion Criteria:~1. Infection~2. Aspiration~3. Significant mechanical lung injury - contusion~4. Infectious diseases : HIV, Hepatitis B and C, HTLV \& Syphilis~5. Malignancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EVLP Group (Type: EXPERIMENTAL): EVLP Group are those recipient lung transplant patients that received donor lungs that had been placed on the ex vivo lung perfusion system with Steen Solution™ .

Based on this trial design, predict the completion outcome and termination type (if applicable).